Cite
MLA Citation
WJ Sandborn et al.. “OC-057 A PH3 Randomised, Multicenter, Double-Blind, Placebo (PBO)-Controlled Study of Ustekinumab (UST) Maintenance Therapy in Moderate–Severe Crohn's Disease (CD) PTS: Results from IM-UNITI.” Gut, vol. 65, n.d., pp. A32–A34. http://access.bl.uk/ark:/81055/vdc_100137792644.0x00004f